Vaccitech, whose backers include Google, has developed genetically modified harmless viruses to prompt the body to respond to the antigens found on the surface of cancer cells. This helps the immune system to attack the cancer. Work on a potential prostate cancer drug is underway, and early lab results have been “very promising” (The Times 6 March 2021).